# Case Report: Whipple’s disease pneumonia caused by inhalation of gas or liquid

**Authors:** Xiaokui Sun, Huizhi Zhu

PMC · DOI: 10.3389/fmed.2025.1664867 · 2025-10-09

## TL;DR

This case report describes two instances of pneumonia caused by the rare bacterium Tropheryma whipplei, linked to aspiration and treated with specific antibiotics.

## Contribution

The study presents two unique clinical cases linking aspiration to T. whipplei pneumonia and highlights effective treatment approaches.

## Key findings

- Two cases of T. whipplei pneumonia were confirmed via mNGS and linked to aspiration.
- Sulfamethoxazole–trimethoprim effectively treated mild T. whipplei pneumonia.
- A co-infection with Aspergillus was successfully treated with meropenem and voriconazole.

## Abstract

Tropheryma whipplei (T. whipplei) is a Gram-positive bacterium that causes rare clinical infections, which primarily manifest as gastrointestinal infections and, more rarely, pulmonary diseases. Furthermore, immunosuppression is considered a predominant risk factor for T. whipplei infection. Several studies have indicated an association between T. whipplei infection and immunocompromised conditions; however, a few studies have also revealed that aspiration may be a potential predisposing factor for T. whipplei-related aspiration pneumonia. This case study reports two different cases of aspiration-induced T. whipplei pneumonia, each exhibiting unique clinical manifestations, imaging features, and therapeutic responses. Both patients had a history of aspiration, and their diagnoses were confirmed via mNGS. They were treated with sulfamethoxazole–trimethoprim (SMZ), which effectively alleviated the symptoms of mild T. whipplei pneumonia. However, in one case, the patient suffered from a severe co-infection of T. whipplei and Aspergillus following a drowning incident, which was effectively treated with meropenem and voriconazole co-therapy. This study provides novel data on T. whipplei infection and improves clinical awareness of aspiration-related pneumonia.

## Linked entities

- **Chemicals:** sulfamethoxazole–trimethoprim (PubChem CID 358641), meropenem (PubChem CID 441130), voriconazole (PubChem CID 71616)
- **Diseases:** Whipple’s disease (MONDO:0005116), pneumonia (MONDO:0005249)
- **Species:** Tropheryma whipplei (taxon 2039)

## Full-text entities

- **Diseases:** Whipple's disease pneumonia (MESH:D008061), pulmonary diseases (MESH:D008171), gastrointestinal infections (MESH:D005767), T. whipplei pneumonia (MESH:D011014), T. whipplei infection (MESH:D007239), aspiration pneumonia (MESH:D011015)
- **Chemicals:** meropenem (MESH:D000077731), SMZ (MESH:D015662), voriconazole (MESH:D065819)
- **Species:** Tropheryma whipplei (species) [taxon 2039], Homo sapiens (human, species) [taxon 9606], Aspergillus (genus) [taxon 5052]

## Figures

5 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12545080/full.md

---
Source: https://tomesphere.com/paper/PMC12545080